Authors' reply: Apixaban, edoxaban and rivaroxaban, but not dabigatran, are associated with higher mortality compared to vitamin K antagonists.
Saved in:
| Title: | Authors' reply: Apixaban, edoxaban and rivaroxaban, but not dabigatran, are associated with higher mortality compared to vitamin K antagonists. |
|---|---|
| Authors: | Engelbertz C; Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, Muenster, Germany., Reinecke H; Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, Muenster, Germany., Köppe J; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany. |
| Source: | Journal of internal medicine [J Intern Med] 2025 Jan; Vol. 297 (1), pp. 119-120. Date of Electronic Publication: 2024 Dec 09. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2796 |
|---|---|
| DOI: | 10.1111/joim.20045 |
